Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
FLAGSHIP VENTURES FUND IV, L.P. (CIK 1503559) reported $381.8M across 3 reported positions in its SEC 13F filing for 2016-03-31. Largest positions: MCRB ($374.1M, 97.96%), TTOO ($7.3M, 1.92%), SESN ($469,000, 0.12%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | MCRB | Seres Therapeutics Inc. | $374.1M | 97.96% | 14.1M | New |
| 2 | TTOO | T2 Biosystems, Inc. | $7.3M | 1.92% | 741,755 | New |
| 3 | SESN | Eleven Biotherapeutics, Inc. | $469,000 | 0.12% | 1.5M | New |
Source: SEC Form 13F filings · as of 2016-03-31